Cargando…
A study investigating the treatment of equine squamous gastric disease with long‐acting injectable or oral omeprazole
BACKGROUND: Equine squamous gastric disease (ESGD) is a highly prevalent disease in horses, particularly in elite athletes. Some horses respond slowly, or fail to respond, to the licensed treatment, oral omeprazole (ORLO). OBJECTIVES: To compare rates of ESGD healing and improvement between ORLO and...
Autores principales: | Gough, Sarah, Hallowell, Gayle, Rendle, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196684/ https://www.ncbi.nlm.nih.gov/pubmed/31945806 http://dx.doi.org/10.1002/vms3.220 |
Ejemplares similares
-
Evaluation of the treatment of equine glandular gastric disease with either long‐acting‐injectable or oral omeprazole
por: Gough, Sarah, et al.
Publicado: (2022) -
Evaluation of a long‐acting injectable formulation of omeprazole in healthy dogs
por: Odunayo, Adesola, et al.
Publicado: (2022) -
Administration of trimethoprim-sulphadimidine does not improve healing of glandular gastric ulceration in horses receiving omeprazole: a randomised, blinded, clinical study
por: Sykes, Ben W, et al.
Publicado: (2014) -
Assessment of agreement using the equine glandular gastric disease grading system in 84 cases
por: Pratt, Stefanie, et al.
Publicado: (2022) -
Diagnostic accuracy of blood sucrose as a screening test for equine gastric ulcer syndrome (EGUS) in adult horses
por: Hewetson, Michael, et al.
Publicado: (2017)